Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Ulta Beauty Inc (ULTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Ulta Beauty Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.47 (market cap $30.93B), while Ulta Beauty Inc trades at $598 (market cap $25.33B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Ulta Beauty Inc pays none. Which is the better fit depends on your goals.
| GEHC | ULTA | |
|---|---|---|
Market Cap | $30.93B | $25.33B |
Volume | 5,033,451 | 603,913 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $706.82 |
52-Week Low | $59.48 | $450.75 |
Enterprise Value | $39.39B | $27.64B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 92 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
ULTA trades at $579.00, up 2.03% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $624.93. Recent Q2 2026 earnings beat expectations, and the company raised its 2026 outlook, driven by e-commerce momentum. Revenue reached $11.30 billion in 2025, though net margin dipped to 9.34%. The stock shows strong profitability with a 46.12% ROE, but faces margin pressure and flat store traffic.
The stock offers upside to analyst targets with solid growth prospects in wellness and omnichannel expansion, but risks include consumer spending volatility, promotional pressures, and insider selling. Execution on raised guidance and margin stability are key for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Ulta Beauty Inc
With more than 1,300 stores and a partnership with Target, Ulta Beauty is the largest specialized beauty retailer in the U.S. The firm offers makeup (43% of 2021 sales), fragrances, skin care, and hair care products (20% of 2021 sales), and bath and body items. Ulta offers private-label products and merchandise from more than 500 vendors. It also offers salon services, including hair, makeup, skin, and brow services, in all stores. Most Ulta stores are approximately 10,000 square feet and are in suburban strip centers. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
Read more on ULTA →
